Sagefield Capital’s Bio-Techne TECH Stock Holding History

Sagefield Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.8M	Buy	+209,647	New	+$11.3M	1.1%	30

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sagefield Capital's TECH Position: Q2 2026 in Review

Sagefield Capital opened a new position in Bio-Techne (TECH) in Q2 2026: 209,647 shares worth $14.8M. The stake represents 1.1% of the portfolio and ranks #30 among its holdings.

593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Sagefield Capital held 209,647 shares of Bio-Techne worth $14.8M as of Q2 2026.
Bio-Techne was a new Sagefield Capital position in Q2 2026.
Bio-Techne made up 1.1% of Sagefield Capital's portfolio in Q2 2026, its #30 holding.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Sagefield Capital's 13F filing for Q2 2026, filed 14 Aug 2026.